Although CYP2C18 was highly correlated with OS and upregulated in PAAD cell lines via qPCR, research on CYP2C18 was mostly concentrated in the gastrointestinal tract and liver, with relatively few studies in pancreatic cancer and lack of immunohistochemistry image in the HPA database. This evidence concerns the gene CYP2C18 and pancreatic neoplasm.